http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018323443-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4383eff7d424f33a5252d6973036a564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8cbbf2290b3f3a9988da29598baa2c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2018-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc276f141da6a99151e2fdef6ff2b300
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87ae5b82dba6cafc49a91e79e7fc9be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_795f723d783c5c3cabfb3c5c1b6237a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea712c408d04bc547674d69ff84d19f7
publicationDate 2020-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2018323443-A1
titleOfInvention Novel gamma aminobutyric acid type a receptor modulators for mood disorders
abstract The present invention relates to novel alpha5 subunit-selective negative allosteric modulators of GABA
priorityDate 2017-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451482292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466152369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426059977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466152370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6484228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468360053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5152094
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7NDN8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467068298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89526634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466152367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466152368

Total number of triples: 43.